Teachers Advisors’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History

Teachers Advisors’s Portfolio CBMG Stock Details CBMG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$266K	Hold	15,375	–	–	﹤0.01%	2767
2018 Q4	$272K	Buy	15,375 +442	+3%	+$7.51K	﹤0.01%	2746
2018 Q3	$271K	Hold	14,933	–	–	﹤0.01%	2853
2018 Q2	$292K	Buy	+14,933	New	+$280K	﹤0.01%	2879
2017 Q2	–	Sell	-18,476	Closed	-$218K	–	3202
2017 Q1	$218K	Hold	18,476	–	–	﹤0.01%	2857
2016 Q4	$242K	Hold	18,476	–	–	﹤0.01%	2850
2016 Q3	$268K	Buy	18,476 +2,007	+12%	+$28.5K	﹤0.01%	2759
2016 Q2	$197K	Hold	16,469	–	–	﹤0.01%	2902
2016 Q1	$307K	Buy	16,469 +2,026	+14%	+$33.6K	﹤0.01%	2603
2015 Q4	$310K	Hold	14,443	–	–	﹤0.01%	2691
2015 Q3	$245K	Hold	14,443	–	–	﹤0.01%	2801
2015 Q2	$542K	Buy	+14,443	New	+$466K	﹤0.01%	2484

Other funds holding CBMG

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Teachers Advisors's CBMG Position: Q1 2019 in Review

Teachers Advisors held its Cellular Biomedicine Group, Inc. (CBMG) position steady in Q1 2019 at 15,375 shares worth $266K. The position accounts for ﹤0.01% of the portfolio, ranked #2767.

Teachers Advisors first reported a position in CBMG in Q2 2015 and has held it in 12 quarters since. The position peaked at $542K in Q2 2015. 40 funds tracked by Wall St. Rank hold CBMG as of Q1 2019.

Teachers Advisors held 15,375 shares of Cellular Biomedicine Group, Inc. worth $266K as of Q1 2019.
Teachers Advisors left its Cellular Biomedicine Group, Inc. share count unchanged in Q1 2019.
Cellular Biomedicine Group, Inc. made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #2767 holding.
Teachers Advisors first reported a position in Cellular Biomedicine Group, Inc. in Q2 2015 and has held it in 12 quarters since.
Teachers Advisors's Cellular Biomedicine Group, Inc. position peaked at $542K in Q2 2015.
40 funds tracked by Wall St. Rank held Cellular Biomedicine Group, Inc. as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.